XML 35 R29.htm IDEA: XBRL DOCUMENT v3.2.0.727
Segments (Tables)
 6 Months Ended
Jun. 30, 2015
Segment Reporting [Abstract]  
Information regarding our geographic activities
Information regarding our operations and assets for our operating segments and the unallocated corporate operations as well as geographic information are as follows:
 
For the three months ended June 30,
 
For the six months ended June 30,
(In thousands)
2015
 
2014
 
2015
 
2014
Product revenues:
 
 
 
 
 
 
 
Pharmaceuticals
$
22,848

 
$
21,392

 
$
38,334

 
$
41,219

Diagnostics
—

 
—

 
—

 
—

Corporate
—

 
—

 
—

 
—

 
$
22,848

 
$
21,392

 
$
38,334

 
$
41,219

Revenue from services:
 
 
 
 
 
 
 
Pharmaceuticals
$
—

 
$
—

 
$
—

 
$
—

Diagnostics
1,848

 
2,093

 
3,857

 
4,003

Corporate
60

 
60

 
120

 
120

 
$
1,908

 
$
2,153

 
$
3,977

 
$
4,123

Revenue from transfer of intellectual property:
 
 
 
 
 
 
 
Pharmaceuticals
$
17,673

 
$
—

 
$
30,202

 
$
285

Diagnostics
—

 
—

 
—

 
191

Corporate
—

 
—

 
—

 
—

 
$
17,673

 
$
—

 
$
30,202

 
$
476

Operating (loss) income:
 
 
 
 
 
 
 
Pharmaceuticals
$
(4,660
)
 
$
(20,368
)
 
$
(42,584
)
 
$
(36,941
)
Diagnostics
(7,098
)
 
(6,805
)
 
(15,575
)
 
(13,882
)
Corporate
(12,905
)
 
(7,038
)
 
(22,882
)
 
(13,174
)
Less: Operating loss attributable to noncontrolling interests
(746
)
 
(674
)
 
(1,281
)
 
(1,163
)
 
$
(25,409
)
 
$
(34,885
)
 
$
(82,322
)
 
$
(65,160
)
Depreciation and amortization:
 
 
 
 
 
 
 
Pharmaceuticals
$
2,371

 
$
2,287

 
$
4,138

 
$
4,135

Diagnostics
1,754

 
1,716

 
3,501

 
3,408

Corporate
27

 
24

 
46

 
48

 
$
4,152

 
$
4,027

 
$
7,685

 
$
7,591

Net loss from investment in investees:
 
 
 
 
 
 
 
Pharmaceuticals
$
(804
)
 
$
(370
)
 
$
(2,565
)
 
$
(2,426
)
Diagnostics
—

 
—

 
—

 
—

Corporate
—

 
—

 
—

 
—

 
$
(804
)
 
$
(370
)
 
$
(2,565
)
 
$
(2,426
)
Revenues:
 
 
 
 
 
 
 
United States
$
2,525

 
$
2,153

 
$
5,019

 
$
4,599

Ireland
19,376

 
—

 
31,480

 
—

Chile
8,698

 
7,852

 
15,150

 
15,136

Spain
4,920

 
5,666

 
8,857

 
11,815

Israel
5,942

 
6,307

 
10,155

 
10,853

Mexico
968

 
1,546

 
1,852

 
3,377

Other
—

 
21

 
—


38

 
$
42,429

 
$
23,545

 
$
72,513

 
$
45,818


(In thousands)
June 30,
2015
 
December 31,
2014
Assets:
 
 
 
Pharmaceuticals
$
1,290,366

 
$
1,064,498

Diagnostics
104,487

 
108,072

Corporate
130,638

 
95,094

 
$
1,525,491

 
$
1,267,664

Goodwill:

 

Pharmaceuticals
$
238,642

 
$
173,327

Diagnostics
50,965

 
50,965

Corporate
—

 
—

 
$
289,607

 
$
224,292